Biocryst Pharmaceuticals Inc. [NASDAQ: BCRX] price plunged by -0.68 percent to reach at -$0.03. The one-year BCRX stock forecast points to a potential upside of 68.31. The average equity rating for BCRX stock is currently 1.33, trading closer to a bullish pattern in the stock
Biocryst Pharmaceuticals Inc. [NASDAQ: BCRX] stock went on a downward path that fall over -0.65% on Wednesday, amounting to a one-week price decrease of less than -5.95%. Over the last 12 months, BCRX stock dropped by -43.25%. The one-year Biocryst Pharmaceuticals Inc. stock forecast points
Biocryst Pharmaceuticals Inc. [NASDAQ: BCRX] closed the trading session at $5.10. The stocks have a year to date performance of -14.86 percent and weekly performance of 10.87 percent. The stock has been moved at -20.31 percent over the last six months. The stock has performed
Biocryst Pharmaceuticals Inc. [NASDAQ: BCRX] price plunged by -7.13 percent to reach at -$0.36. The company report on March 25, 2024 at 4:01 PM that BioCryst to Present at Upcoming Investor Conferences. Links to the live audio webcasts and replays of the presentations may be
Biocryst Pharmaceuticals Inc. [NASDAQ: BCRX] surged by $0.02 during the normal trading session on while it closed the day at $5.49. The company report on March 5, 2024 at 7:01 AM that BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4). The options have an
Biocryst Pharmaceuticals Inc. [NASDAQ: BCRX] slipped around -0.25 points on Thursday, while shares priced at $4.89 at the close of the session, down -4.86%. The company report on March 5, 2024 at 7:01 AM that BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4). The
Biocryst Pharmaceuticals Inc. [NASDAQ: BCRX] traded at a low on Wednesday, posting a -3.70 loss after which it closed the day’ session at $5.21. The company report on March 5, 2024 at 7:01 AM that BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4). The
Biocryst Pharmaceuticals Inc. [NASDAQ: BCRX] closed the trading session at $5.57. The company report on February 12, 2024 at 7:00 AM that BioCryst to Report Fourth Quarter 2023 Financial Results on February 26. BioCryst management will host a conference call and webcast at 8:30 a.m.
© 2024, Powered by Smart TechOne
